Literature DB >> 28960532

Late infections and secondary malignancies after bendamustine/rituximab or RCHOP/RCVP chemotherapy for B-cell lymphomas.

Adam J Olszewski1,2, John L Reagan1,2, Jorge J Castillo3,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28960532     DOI: 10.1002/ajh.24921

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

Review 1.  Management of Mantle Cell Lymphoma in the Era of Novel Oral Agents.

Authors:  Michael J Buege; Anita Kumar; Brianne N Dixon; Laura A Tang; Terry Pak; Jennifer Orozco; Tim J Peterson; Kathryn T Maples
Journal:  Ann Pharmacother       Date:  2020-02-20       Impact factor: 3.154

2.  Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells.

Authors:  Ana Cordeiro; Evandro D Bezerra; Alexandre V Hirayama; Joshua A Hill; Qian V Wu; Jenna Voutsinas; Mohamed L Sorror; Cameron J Turtle; David G Maloney; Merav Bar
Journal:  Biol Blood Marrow Transplant       Date:  2019-08-13       Impact factor: 5.742

3.  Combination lenalidomide-rituximab immunotherapy activates anti-tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma.

Authors:  Hsiling Chiu; Preeti Trisal; Chad Bjorklund; Soraya Carrancio; Estela G Toraño; Carla Guarinos; Despoina Papazoglou; Patrick R Hagner; Asma Beldi-Ferchiou; Karin Tarte; Marie-Hélène Delfau-Larue; Franck Morschhauser; Alan G Ramsay; Anita K Gandhi
Journal:  Br J Haematol       Date:  2019-02-14       Impact factor: 6.998

4.  An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma.

Authors:  Juan Pablo Alderuccio; Luca Arcaini; Marcus P Watkins; Anne W Beaven; Geoffrey Shouse; Narendranath Epperla; Michele Spina; Alexandra Stefanovic; Jose Sandoval-Sus; Pallawi Torka; Ash B Alpert; Adam J Olszewski; Seo-Hyun Kim; Brian Hess; Sameh Gaballa; Sabarish Ayyappan; Jorge J Castillo; Lisa Argnani; Timothy J Voorhees; Raya Saba; Sayan Mullick Chowdhury; Fernando Vargas; Isildinha M Reis; Deukwoo Kwon; Jonathan S Alexander; Wei Zhao; Dali Edwards; Peter Martin; Emanuele Cencini; Manali Kamdar; Brian K Link; Constantine N Logothetis; Alex F Herrera; Jonathan W Friedberg; Brad S Kahl; Stefano Luminari; Pier Luigi Zinzani; Izidore S Lossos
Journal:  Blood Adv       Date:  2022-04-12

5.  Vincristine Sulfate Liposome Injection with Bendamustine and Rituximab as First-Line Therapy for B-Cell Lymphomas: A Phase I Study.

Authors:  Thomas Ollila; James Butera; Pamela Egan; John Reagan; Anthony Thomas; Inna Yakirevich; Kelsey MacKinnon; Jeannine Margolis; Jessica McMahon; Valerie Rosati; Adam J Olszewski
Journal:  Oncologist       Date:  2022-07-05       Impact factor: 5.837

6.  Cause-specific mortality in individuals with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia, 2000-2016.

Authors:  Nicole H Dalal; Graça M Dores; Rochelle E Curtis; Martha S Linet; Lindsay M Morton
Journal:  Br J Haematol       Date:  2020-02-23       Impact factor: 8.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.